Trejo SÓ, García MMC, Tolentino LJA, López VJL

Language: Spanish
References: 15
Page: 229-230
PDF size: 77.82 Kb.

ABSTRACT

The methodology to evaluation of the patients with anormal cytology, must include the accomplishment of a colposcopic examination in order to discover the changes in the epithelium of the cervix according to its pathology. Colposcopy should be due to carry out in a systematized form, which will allow to classify the lesions and to propose the most suitable and effective treatment for each case. In 1999 in the clinic of colposcopy of the Hospital Adolfo López Mateos ISSSTE, was developed a scale of calification of low (LSIL) and high (HSIL) grade squamous intraepithelial lesions, using parameters such as: color, degree of acetic acid changes, relief, punctation and mosaicism, margins, number, location, and size, and changes with iodine staining, and if the colposcopy was satisfactory or not. We propose a colposcopic index with the next punctuations: 1-12 for LSIL, 13-24 for HSIL. The most important target of this, was to discard invasive lesions.

REFERENCES

1. Lazcano-Ponce E, Alonso P, Ruiz- Moreno JA, Hernández-Ávila M. Recomendaciones a programas de detección oportuna de cáncer cervical en países en desarrollo. Necesidad de equidad y desarrollo tecnológico. Salud Publica Mex 2003; 45 Suppl 3: 5449-5462.

2. Lazcano PE, Najera P, Alonso P, Kuri P, Cantoral L, Hernandez M. The cervical cancer screening program in Mexico. Problems with access and coverage. Cancer Causes & Control 1997; 8: 698-704.

3. Lazcano PEC, Moss S, Cruz VA, Alonso RP, Caseres QS, Martínez LJ, Hernández AM. Factores que determinan la participación en el tamizaje de cáncer cervical en el estado de Morelos. Revista de Salud Publica de Mexico 199; 41: 278-285.

4. Koss LG. The Papanicolaou test for cervical cancer detection. A triumph and a tragedy. JAMA 1989; 261: 737-743.

5. Bergeron C, Jeannel D, Poveda J, Cassonet P, Orth G. Human papillomavirus testing in women with mild cytologic atypia. Obstet Gynecol 2000; 95: 821-827.

6. Ho GY, Bierman R, Berardsley L, Chang CJ, Burk RD. Natural history of cervicovaginal papillomavirus infection in young women. N Engl J Med 1998; 338: 423-428.

7. Palefsky JM, Holly EA. Immunosuppression and co-infection with HIV. J Natl Cancer Inst Monogr 2003; 6(31): 41-6.

8. Clavel C, Masure M, Bory JP, Putaud I, Mangeonjean C, Lorenzato M et al. Human papillomavirus testing in primary screening for the detection of high- grade cervical lesions: a study of 7,932 women. Br J Cancer 2001; 84: 1616-1623.

9. National Cancer Institute Workshop. The 1988 Bethesda System for reporting cervical/vaginal cytological diagnoses. JAMA 1989; 262: 931-934.

10. Solomon D, Davey D, Kurman R, Moriarty A, O´Conner D, Prey M et al. The 2001 Bethesda system: terminology for reporting results of cervical cytology. JAMA 2002; 124: 2114-2119.

11. Hopman EH, Kenemans P, Helmerhorst TJM. Positive predictive rate of colposcopic examination of the cervix uteri: an overview of the literature. Obstet Gynecol Survey 1998; 53: 97-106.

12. Kolstad P. The colposcopic diagnosis of dysplasias, carcinoma in situ, and early invasive cancer of the cervix. Acta Obstet Gynec Scand 1964; 43: 105-8.

13. Mitchell MF, Schottenfeld D, Tortolero-Luna G, Cantor SB, Richards-Kortum R. Colposcopy for the diagnosis of squamous intraepithelial lesions: a meta-analysis. Obstet Gynecol 1998; 91: 626-631.

14. Coppelson M, Pixley EC, Reid B. Colposcopy: A scientific and practical approach to the cervix, vagina and vulva in health disease. 3rd ed. Springfield, IL. Charles C. Thomas, 1987.

15. Burghardt E, Ostor AG. Colposcopy, cervical pathology. Textbook and Atlas. New York. Thieme Stratton 1984.